re: thoratec tanking & syringe is fair. 1. I can tell you that in my research I have found an expert who thinks the product is OK. I want to be fair and say that. This is the first positive thing I have heard.
2. Thoratec has tanked as indicated by the poster. The reason being that it overestimated the size of the market. Similarly the other standout company Abiomed makes no money. Not a bullish sign.
3. This is not a cut and paste from a competitor. The article is sourced to the University of Columbia and not a doctor working on improving or developing the device and misleadingly called a 'medical investigator'. The doctors are real doctors and not a miserable PhD calling themselves doctor as the CEO of VCR has done.
- Forums
- ASX - By Stock
- VCR
- prop is now the seller.....
VCR
ventracor limited
prop is now the seller....., page-22
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Currently unlisted public company.
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online